ANI Pharmaceuticals, Inc. (ANIP)
78.20
+1.72
(+2.25%)
USD |
NASDAQ |
Apr 16, 16:00
78.20
0.00 (0.00%)
After-Hours: 19:37
ANI Pharmaceuticals Research and Development Expense (Quarterly) : 12.26M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Liquidia Corp. | 16.72M |
| Catalyst Pharmaceuticals, Inc. | 1.807M |
| Indivior Pharmaceuticals, Inc. | 17.00M |
| Replimune Group, Inc. | 52.87M |
| ADMA Biologics, Inc. | 1.376M |